Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men - United States, 2003, and revised recommendations for gonorrhea treatment, 2004

Morbidity and Mortality Weekly Report

Volumn 53, Issue 16, 2004, Pages 335-338

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; GONORRHEA; HEALTH SURVEY; HOMOSEXUALITY; HUMAN; MALE; MICROBIOLOGY; NEISSERIA GONORRHOEAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GONORRHEA; HOMOSEXUALITY, MALE; HUMANS; MALE; MASSACHUSETTS; NEISSERIA GONORRHOEAE; NEW YORK CITY; POPULATION SURVEILLANCE; UNITED STATES;

EID: 2342560561     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Institute of Medicine, Division of Health Promotion and Disease Prevention. The hidden epidemic: confronting sexually transmitted diseases. Eng TR, Butler WT, eds. Washington, DC: National Academy Press, 1997.
2. Weinstock H, Berman S, Cates W. Sexually transmitted infections in American youth: incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health 2004;36:6-10.
3. CDC. Fluoroquinolone-resistance in Neisseria gonorrhoeae in Hawaii, 1999 and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. MMWR 2000;49:833-6.
4. CDC. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002;51 (No. RR-6).
5. CDC. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae Hawaii and California, 2001. MMWR 2002;51:1041-4.
6. CDC. Sexually Transmitted Disease Surveillance 2002 Supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report 2002. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, 2003.
7. Tapsall J. Antimicrobial resistance in Neisseria gonorrhoeae. Geneva, Switzerland: World Health Organization, 2001; WHO/CDS/DRS/2001.3:16.
8. Fenton KA, Ison C, Johnson AP, et al. Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet 2003;361:1867-9.
9. CDC. Discontinuation of cefixime tablets - United States. MMWR 2002;51:1052.
10. CDC. Oral alternatives to cefixime for the treatment of uncomplicated Neisseria gonorrhoeae urogenital infections. Available at http://www.cdc.gov/ std/treatment/cefixime.htm.